Farquharson is the founder of NuSpecies, a New York corporation headquartered in Pawling, New York, that makes raw, natural, organic formulas that are 99 percent liquid. He began developing the concepts behind the company about 30 years ago, while he was still working in corporate law, and started manufacturing about 22 years ago. At Fried Frank, he worked on global corporate M&A deals. At IBM Legal, as a Contracts Negotiation Executive, he led and co-led negotiations on global outsourcing deals. He was also the lead inventor on three IBM patents (U.S. Patent 7,363,509, granted April 22, 2008; U.S. Patent 7,971,068, granted June 28, 2011; and U.S. Patent 8,275,670, granted September 25, 2012). For that work, he led US IBM Research software engineers and IBM executives and lawyers worldwide to institutionalize the company’s first global legal e-signature Contracts Online platforms, which IBM clients worldwide could also use. NuSpecies ran first as a charitable foundation before it became an incorporated practice in 2007, and today one of its premier locations sits in Bronxville, New York, in Westchester County. The Mathematics Of Becoming belongs to a larger body of writing he calls the Singularity Dual-Aspect Emergence (SDAE) Canon, published through NuSpecies Press, also based in Pawling.

The Canon organizes everything Farquharson has built into what he calls the symbolic mathematics and geometry of health. It rests on established empirical science. Where science has no answer yet, the books move into what he calls SDAE Metaphysics, and he labels that shift rather than hiding it.

What the Practice Saw

Farquharson says the Canon grew out of clinical work. For more than two decades, NuSpecies products and formulas were administered to tens of thousands of clients by nurse practitioners, registered nurses, certified dietitians, nutritionists, and life coaches. The company waited for that record to build before it brought medical doctors on staff.

Many of those clients came to the practice sick, and Farquharson knew that experience from his own family. He founded NuSpecies because of his father, who suffered for years with prostate cancer before he died of it. His mother’s long suffering with diabetes, which cost her amputations before she died of its complications, gave him a second reason. Watching isolated, synthetic treatments fail them both pushed him toward whole-food formulas, and he says he built the company to help others.

The Canon’s two dimensions come from that history. The Outer dimension covers physical structure: the body a practitioner can examine and, at a larger scale, the planet. The Inner dimension covers a person’s internal energy, experience, and awareness. The Canon treats the two as aspects of one source rather than separate systems, which is where the “dual-aspect” in its name comes from.

The same split shaped Farquharson’s other project. He engineered the NuPlanet machine prototypes, aimed at planetary health, alongside the NuSpecies formulas, aimed at human health. He describes the machine as a self-powered, renewable electricity generator and says he designed it with one goal: giving humanity enough energy to defend the planet against an extinction-level asteroid. The prototypes are not yet fully patented, and he plans to file in the future.

Symbolic Mathematics, Not Proven Equations

The Mathematics Of Becoming sets out the Canon’s equations through figures Farquharson calls Geometrogenesis, the Cathedral Equation, and Relational Balance, each meant to model how a living system holds together under stress. He describes them as symbolic mathematics and geometric equations that are empirically informed by two decades of NuSpecies Integrative Practice with sick clients, and he says plainly that the equations are not empirically proven.

“I’m not asking anyone to take this on faith,” he says. “I’m asking them to read it and decide for themselves whether the argument holds up. That’s a different thing from a promise.”

Farquharson wrote most of the Canon’s concepts over a 30-year span and expected them to stay private. He credits much of the books’ inspiration to his mother’s sacred spirituality and to the NuSpecians. He says he decided to publish only after enough clients and friends asked him to explain his thinking that a book seemed faster than repeating the same conversation.

The line between symbolic and proven matters for a business built around supplements, a category regulators watch closely for language that edges into treatment claims. NuSpecies formulas are cold-processed, organic and wild-crafted, made in the United States, certified under Good Manufacturing Practices (GMP), and tested independently by a third-party lab using high-performance thin-layer chromatography (HPTLC). Every ingredient appears on the FDA’s Generally Recognized as Safe (GRAS) list, and the products fall under FDA regulation. The line covers plant-based formulas and non-vegan formulas with fatty acids, amino acids, and omega-3 and omega-6. The company markets its formulas as whole-food ingredients rather than remedies for any named condition, and Farquharson says it has never filed a health claim with regulators.

A Slow Build, By Design

The US herbal supplements market was valued at 12.29 billion US dollars in 2025 and is projected to reach 13.29 billion US dollars in 2026, according to a market report from MarkNtel Advisors, which attributes the growth to rising consumer interest in preventive health and natural wellness. Farquharson says NuSpecies has grown alongside that trend without building its identity around it. Most of its clients, he says, found the practice through word of mouth while managing a health concern, not through advertising built on the book.

He has no plans to stop writing, even as the business takes up most of his time. He describes The Mathematics Of Becoming as an ongoing project that he expects to revise as the practice’s clinical record grows and as testing continues on the NuPlanet prototypes. For now, the book is the clearest public account of the path that took him from a law office to a health company, and he says he is in no hurry to tidy that story into something simpler than it was.